Covaxin booster dose neutralizes Omicron and Delta variant, says study |
Clinical News
eMediNexus Coverage from: 
Covaxin booster dose neutralizes Omicron and Delta variant, says study

7 Read Comments                

A booster dose of Baharat Biotech’s COVID-19 vaccine, Covaxin, administered 6 months after the primary vaccine series, has been reported to effectively neutralize both Omicron and Delta variants of the coronavirus in a study conducted at Emory University.Bharat Biotech said that the study was conducted using a live virus neutralization assay and it was found that the booster dose of Covaxin evoked strong neutralizing antibody responses against Omicron and Delta. The company stated that 100...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now